Differential effects of viral vectors on migratory afferent lymph dendritic cells in vitro predict enhanced immunogenicity in vivo

Journal of Virology

Volumn 85, Issue 18, 2011, Pages 9385-9394

  Cubillos Zapata, C ^a   Guzman, E ^a   Turner, A ^b   Gilbert, S C ^b   Prentice, H ^a   Hope, J C ^a   Charleston, B ^a  

^a INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; RECOMBINANT FOWLPOX VIRUS VECTOR; RECOMBINANT HUMAN REPLICATION DEFECTIVE HUMAN ADENOVIRUS 5 VECTOR; RECOMBINANT MODIFIED VACCINIA VIRUS ANKARA VECTOR; UNCLASSIFIED DRUG; VIRUS ANTIGEN; VIRUS VECTOR;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CALF (BOVINE); CD4+ T LYMPHOCYTE; CELL INTERACTION; CELL MIGRATION; CELL PROLIFERATION; CELL SELECTION; CONTROLLED STUDY; DENDRITIC CELL; FOOT AND MOUTH DISEASE VIRUS; IMMUNIZATION; IMMUNOGENICITY; IN VITRO STUDY; IN VIVO STUDY; INCUBATION TIME; LYMPHOCYTE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

ADENOVIRUSES, HUMAN; ANIMALS; ANTIGENS, VIRAL; CATTLE; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELL SURVIVAL; DENDRITIC CELLS; FOOT-AND-MOUTH DISEASE VIRUS; FOWLPOX VIRUS; LYMPH NODES; VACCINATION; VACCINES, SYNTHETIC; VACCINIA VIRUS; VIRAL VACCINES;

FOOT-AND-MOUTH DISEASE VIRUS; FOWLPOX VIRUS; HUMAN ADENOVIRUS TYPE 5; RODENTIA; VACCINIA VIRUS ANKARA;

EID: 80052497990     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.05127-11     Document Type: Article

References (62)

1. Banzhoff, A., P. Nacci, and A. Podda. 2003. A new MF59-adjuvanted influenza vaccine enhances the immune response in the elderly with chronic diseases: results from an immunogenicity meta-analysis. Gerontology 49: 177-184.
2. Bonneau, M., et al. 2006. Migratory monocytes and granulocytes are major lymphatic carriers of Salmonella from tissue to draining lymph node. J. Leukoc. Biol. 79:268-276.
3. Boulanger, D., P. Green, T. Smith, C. P. Czerny, and M. A. Skinner. 1998. The 131-amino-acid repeat region of the essential 39-kilodalton core protein of fowlpox virus FP9, equivalent to vaccinia virus A4L protein, is nonessential and highly immunogenic. J. Virol. 72:170-179.
4. Brooke, G. P., K. R. Parsons, and C. J. Howard. 1998. Cloning of two members of the SIRP alpha family of protein tyrosine phosphatase binding proteins in cattle that are expressed on monocytes and a subpopulation of dendritic cells and which mediate binding to CD4 T cells. Eur. J. Immunol. 28:1-11.
5. Butcher, E. C., and L. J. Picker. 1996. Lymphocyte homing and homeostasis. Science 272:60-66.
6. Cheng, C., et al. 2007. Mechanism of ad5 vaccine immunity and toxicity: fiber shaft targeting of dendritic cells. PLoS Pathog. 3:e25.
7. Cheong, C., et al. 2010. Improved cellular and humoral immune responses in vivo following targeting of HIV Gag to dendritic cells within human antihuman DEC205 monoclonal antibody. Blood 116:3828-3838.
8. Coffman, R. L., A. Sher, and R. A. Seder. 2010. Vaccine adjuvants: putting innate immunity to work. Immunity 33:492-503.
9. Collen, T., and T. R. Doel. 1990. Heterotypic recognition of foot-and-mouth disease virus by cattle lymphocytes. J. Gen. Virol. 71:309-315.
10. Collins, R. A., E. B. Camon, P. J. Chaplin, and C. J. Howard. 1998. Influence of IL-12 on interferon-gamma production by bovine leucocyte subsets in response to bovine respiratory syncytial virus. Vet. Immunol. Immunopathol. 63:69-72.
11. Contreras, V., et al. 2010. Existence of CD8alpha-like dendritic cells with a conserved functional specialization and a common molecular signature in distant mammalian species. J. Immunol. 185:3313-3325.
12. Crozat, K., et al. 2010. The XC chemokine receptor 1 is a conserved selective marker of mammalian cells homologous to mouse CD8alpha+ dendritic cells. J. Exp. Med. 207:1283-1292.
13. Dominguez, J., M. M. Lorenzo, and R. Blasco. 1998. Green fluorescent protein expressed by a recombinant vaccinia virus permits early detection of infected cells by flow cytometry. J. Immunol. Methods 220:115-121.
14. Drexler, I., C. Staib, and G. Sutter. 2004. Modified vaccinia virus Ankara as antigen delivery system: how can we best use its potential? Curr. Opin. Biotechnol. 15:506-512.
15. Dupuis, M., et al. 1998. Dendritic cells internalize vaccine adjuvant after intramuscular injection. Cell. Immunol. 186:18-27.
16. Ellis, J. A., W. I. Morrison, B. M. Goddeeris, and D. L. Emery. 1987. Bovine mononuclear phagocytic cells: identification by monoclonal antibodies and analysis of functional properties. Vet. Immunol. Immunopathol. 17:125-134.
17. Engelmayer, J., et al. 1999. Vaccinia virus inhibits the maturation of human dendritic cells: a novel mechanism of immune evasion. J. Immunol. 163: 6762-6768.
18. Epardaud, M., et al. 2004. Enrichment for a CD26hi SIRP- subset in lymph dendritic cells from the upper aero-digestive tract. J. Leukoc. Biol. 76:553-561.
19. Gliddon, D. R., J. C. Hope, G. P. Brooke, and C. J. Howard. 2004. DEC-205 expression on migrating dendritic cells in afferent lymph. Immunology 111: 262-272.
20. Gliddon, D. R., and C. J. Howard. 2002. CD26 is expressed on a restricted subpopulation of dendritic cells in vivo. Eur. J. Immunol. 32:1472-1481.
21. Granelli-Piperno, A., et al. 2005. Dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin/CD209 is abundant on macrophages in the normal human lymph node and is not required for dendritic cell stimulation of the mixed leukocyte reaction. J. Immunol. 175:4265-4273.
22. Guermonprez, P., J. Valladeau, L. Zitvogel, C. Thery, and S. Amigorena. 2002. Antigen presentation and T cell stimulation by dendritic cells. Annu. Rev. Immunol. 20:621-667.
23. Gulen, D., et al. 2008. Closing the manufacturing process of dendritic cell vaccines transduced with adenovirus vectors. Int. Immunopharmacol. 8:1728-1736.
24. Hope, J. C., C. J. Howard, H. Prentice, and B. Charleston. 2006. Isolation and purification of afferent lymph dendritic cells that drain the skin of cattle. Nat. Protoc. 1:982-987.
25. Hope, J. C., et al. 2002. Development of detection methods for ruminant interleukin (IL)-12. J. Immunol. Methods 266:117-126.
26. Hope, J. C., et al. 2005. Exposure to Mycobacterium avium induces low-level protection from Mycobacterium bovis infection but compromises diagnosis of disease in cattle. Clin. Exp. Immunol. 141:432-439.
27. Howard, C. J., et al. 1999. Dendritic cells in cattle: phenotype and function. Vet. Immunol. Immunopathol. 72:119-124.
28. Howard, C. J., et al. 1991. Summary of workshop findings for leukocyte antigens of cattle. Vet. Immunol. Immunopathol. 27:21-27.
29. Howard, C. J., and J. Naessens. 1993. Summary of workshop findings for cattle (tables 1 and 2). Vet. Immunol. Immunopathol. 39:25-47.
30. Howard, C. J., et al. 1997. Identification of two distinct populations of dendritic cells in afferent lymph that vary in their ability to stimulate T cells. J. Immunol. 159:5372-5382.
31. Huang, F. P., et al. 2000. A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes. J. Exp. Med. 191:435-444.
32. Jakubzick, C., et al. 2008. Lymph-migrating, tissue-derived dendritic cells are minor constituents within steady-state lymph nodes. J. Exp. Med. 205:2839-2850.
33. Johansen, P., D. Mohanan, J. M. Martinez-Gomez, T. M. Kundig, and B. Gander. 2010. Lympho-geographical concepts in vaccine delivery. J. Control. Release 148:56-62.
34. Kwong, L. S., et al. 2002. Development of an ELISA for bovine IL-10. Vet. Immunol. Immunopathol. 85:213-223.
35. Li, W. H., Y. Zhang, S. H. Wang, L. Liu, and F. Yang. 2003. Recombinant replication-defective adenovirus based rabies vaccine. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 25:650-654.
36. Liu, L., R. Chavan, and M. B. Feinberg. 2008. Dendritic cells are preferentially targeted among hematolymphocytes by Modified Vaccinia Virus Ankara and play a key role in the induction of virus-specific T cell responses in vivo. BMC Immunol. 9:15.
37. Liu, L., M. Zhang, C. Jenkins, and G. G. MacPherson. 1998. Dendritic cell heterogeneity in vivo: two functionally different dendritic cell populations in rat intestinal lymph can be distinguished by CD4 expression. J. Immunol. 161:1146-1155.
38. Liu, Y., et al. 2006. Hierarchy of alpha fetoprotein (AFP)-specific T cell responses in subjects with AFP-positive hepatocellular cancer. J. Immunol. 177:712-721.
39. Lundqvist, A., et al. 2002. Nonviral and viral gene transfer into different subsets of human dendritic cells yield comparable efficiency of transfection. J. Immunother. 25:445-454.
40. MacPherson, G. G., and C. W. Pugh. 1984. Heterogeneity amongst lymphborne "dendritic" cells. Immunobiology 168:338-348.
41. Mayr, A., and K. Malicki. 1966. Attenuation of virulent fowl pox virus in tissue culture and characteristics of the attenuated virus. Zentralbl. Veterinarmed. B 13:1-13.
42. McKeever, D. J., E. Awino, and W. I. Morrison. 1992. Afferent lymph veiled cells prime CD4 T cell responses in vivo. Eur. J. Immunol. 22:3057-3061.
43. McKeever, D. J., N. D. MacHugh, B. M. Goddeeris, E. Awino, and W. I. Morrison. 1991. Bovine afferent lymph veiled cells differ from blood monocytes in phenotype and accessory function. J. Immunol. 147:3703-3709.
44. Milling, S., U. Yrlid, V. Cerovic, and G. MacPherson. 2010. Subsets of migrating intestinal dendritic cells. Immunol. Rev. 234:259-267.
45. Mosca, F., et al. 2008. Molecular and cellular signatures of human vaccine adjuvants. Proc. Natl. Acad. Sci. U. S. A. 105:10501-10506.
46. Pacheco, J. M., M. C. Brum, M. P. Moraes, W. T. Golde, and M. J. Grubman. 2005. Rapid protection of cattle from direct challenge with foot-and-mouth disease virus (FMDV) by a single inoculation with an adenovirus-vectored FMDV subunit vaccine. Virology 337:205-209.
47. Palucka, K., J. Banchereau, and I. Mellman. 2010. Designing vaccines based on biology of human dendritic cell subsets. Immunity 33:464-478.
48. Peng, Y., et al. 2007. Innate and adaptive immune response to apoptotic cells. J. Autoimmun. 29:303-309.
49. Rossi, M., and J. W. Young. 2005. Human dendritic cells: potent antigenpresenting cells at the crossroads of innate and adaptive immunity. J. Immunol. 175:1373-1381.
50. Sallusto, F., M. Cella, C. Danieli, and A. Lanzavecchia. 1995. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J. Exp. Med. 182:389-400.
51. Sauter, B., et al. 2000. Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J. Exp. Med. 191:423-434.
52. Seubert, A., E. Monaci, M. Pizza, D. T. O'Hagan, and A. Wack. 2008. The adjuvants aluminum hydroxide and MF59 induce monocyte and granulocyte chemoattractants and enhance monocyte differentiation toward dendritic cells. J. Immunol. 180:5402-5412.
53. Steinman, R. M. 1991. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9:271-296.
54. Stephens, S. A., J. Brownlie, B. Charleston, and C. J. Howard. 2003. Differences in cytokine synthesis by the sub-populations of dendritic cells from afferent lymph. Immunology 110:48-57.
55. Streilein, J. W., S. F. Grammer, T. Yoshikawa, A. Demidem, and M. Vermeer. 1990. Functional dichotomy between Langerhans cells that present antigen to naive and to memory/effector T lymphocytes. Immunol. Rev. 117:159-183.
56. Tartaglia, J., et al. 1992. NYVAC: a highly attenuated strain of vaccinia virus. Virology 188:217-232.
57. Tsuji, T., et al. 2011. Antibody-targeted NY-ESO-1 to mannose receptor or DEC-205 in vitro elicits dual human CD8+ and CD4+ T cell responses with broad antigen specificity. J. Immunol. 186:1218-1227.
58. Wack, A., et al. 2008. Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice. Vaccine 26:552-561.
59. Whelan, A. O., et al. 2003. Modulation of the bovine delayed-type hypersensitivity responses to defined mycobacterial antigens by a synthetic bacterial lipopeptide. Infect. Immun. 71:6420-6425.
60. Yrlid, U., and G. Macpherson. 2003. Phenotype and function of rat dendritic cell subsets. APMIS 111:756-765.
61. Zhang, W. W. 1999. Development and application of adenoviral vectors for gene therapy of cancer. Cancer Gene Ther. 6:113-138.
62. Zhang, X., et al. 2007. Direct comparison of antigen production and induction of apoptosis by canarypox virus- and modified vaccinia virus Ankarahuman immunodeficiency virus vaccine vectors. J. Virol. 81:7022-7033.